DIA Biosimilars 2013

Mount Sinai School of Medicine

GNS Healthcare, Dana-Farber, Mount Sinai to build computer model of multiple myeloma

Tuesday, November 13, 2012 01:57 PM

GNS Healthcare, a healthcare data analytics company, has entered into a collaboration with Dana-Farber Cancer Institute and the Mount Sinai School of Medicine to create a data-driven computer model of multiple myeloma, the second most common blood cancer in the U.S.

More... »

Cenduit: Now with Patient Reminders

Rejected Alzheimer's drug shows new potential

Wednesday, August 1, 2012 11:42 AM

An international team of scientists led by researchers at Mount Sinai School of Medicine have discovered that a drug that had previously yielded conflicting results in clinical trials for Alzheimer's disease effectively stopped the progression of memory deterioration and brain pathology in mouse models of early stage Alzheimer's disease. The findings, published July 31, 2012, in Molecular Psychiatry, demonstrate renewed potential for this compound and could lead to clinical trials in patients with early stages of the disease.

More... »

CRF Health – eCOA Forum

Mount Sinai researchers develop multi-target approach to treating tumors

Friday, June 8, 2012 02:38 PM

Researchers from Mount Sinai School of Medicine developed a cancer model built in the fruit fly Drosophila, then used it to create a whole new approach to the discovery of cancer treatments: AD80.

More... »

CenterWatch Drugs in Clinical Trials Database Library. Drug intelligence right at your fingertips.
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

Copyright © 1995-2013 CenterWatch.